Ozone oxidation of oestrogenic active substances in wastewater and drinking water

被引:20
作者
Baig, S. [1 ]
Hansmann, G. [2 ]
Paolini, B. [2 ]
机构
[1] Degremont SA, F-92500 Rueil Malmaison, France
[2] Degremont Technol Ltd, CH-8600 Dubendorf, Switzerland
关键词
drinking water; endocrine disruptors; oestrogens; ozone; ozone dose; pharmaceuticals; wastewater;
D O I
10.2166/wst.2008.665
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Ozone oxidation is proven to be an effective solution for the degradation of selected oestrogenic active substances detected in secondary wastewaters such as beta-oestradiol, oestrone, oestriol, 17-alpha-ethinyloestradiol, mestranol, daidzeine, beta-sitosterol, bisphenol A, norethisterone, 4-tert-octylphenol and 4-iso-nonylphenol, up to their limit of detection. The matrix-effect of wastewater was investigated performing ozone experiments under batch mode and continuous mode using drinking water and a wastewater issued from a local plant both spiked with the non-detected substances. The results obtained indicate that the wastewater matrix greatly affects the kinetics of ozone reaction with these substances but does not really change the related reactivity scale. The ozone dose corresponding to the full conversion of target EDCs consequently increases as their oxidation takes place competing with reactions of background pollutants represented by the COD and DOC content. However, a usual dose close to 12 mg/L was found sufficient to provide high degradation yields for all substances studied while 35% of COD was removed. This is a contribution to the numerous current works focused on technologies able to improve the quality of water discharged from wastewater treatment plants, both considering conventional parameters and emerging contaminants.
引用
收藏
页码:451 / 458
页数:8
相关论文
共 8 条
[1]   Removal of estrogenic activity and formation of oxidation products during ozonation of 17α-ethinylestradiol [J].
Huber, MM ;
Ternes, TA ;
von Gunten, U .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2004, 38 (19) :5177-5186
[2]   Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: A review [J].
Ikehata, Keisuke ;
Naghashkar, Naeimeh Jodeiri ;
Ei-Din, Mohamed Gamal .
OZONE-SCIENCE & ENGINEERING, 2006, 28 (06) :353-414
[3]  
*POSEIDON EU, 2004, ASS TECHN REM PHARM
[4]  
Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554
[5]   Degradation of endocrine disrupting chemicals bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation processes [J].
Rosenfeldt, EJ ;
Linden, KG .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2004, 38 (20) :5476-5483
[6]   Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry [J].
Snyder, SA ;
Westerhoff, P ;
Yoon, Y ;
Sedlak, DL .
ENVIRONMENTAL ENGINEERING SCIENCE, 2003, 20 (05) :449-469
[7]   Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater [J].
Snyder, Shane A. ;
Wert, Eric C. ;
Rexing, David J. ;
Zegers, Ronald E. ;
Drury, Douglas D. .
OZONE-SCIENCE & ENGINEERING, 2006, 28 (06) :445-460
[8]  
SUTER MJF, 2002, EAWAG NEWS, V53, P24